Higher doses tested for Tough-to-Treat schizophrenia
NCT ID NCT00539071
Summary
This study tested whether higher doses of a long-acting injectable antipsychotic medication (risperidone) work better than standard doses for people with schizophrenia or schizoaffective disorder whose symptoms aren't well controlled. 160 participants who hadn't responded well to their current medication received either the standard dose or a higher dose for six months. Researchers compared how much symptoms improved between the two groups.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanderbilt Psychiatric Hospital
Nashville, Tennessee, 37212-8645, United States
Conditions
Explore the condition pages connected to this study.